TY - JOUR
TI - First-line bortezomib benefits patients with multiple myeloma
AU - Dimopoulos, Meletios A
AU - Terpos, Evangelos
JO - Nature Reviews Clinical Oncology
PY - 2009
VL - 6
TODO - 12
SP - 683--685
PB - Nature Publishing Group
SN - 1759-4774, 1759-4782
TODO - null
TODO - null
TODO - null
ER -